-transparent.png){kind=logo}
Twenty-five patients with histologically proven small cell lung cancer who were in too poor physical condition to receive 'aggressive' chemotherapy were treated with vindesine and etoposide (VE). The median survival was 195 days, and there were 4 survivors of greater than 460 days. Eight patients died before the second pulse of chemotherapy, and these all had a Karnofsky score of less than or equal to 20 at diagnosis. Toxicity of the chemotherapy regimen was minimal, and the results suggest that VE chemotherapy may be suitable for the treatment of patients with small cell lung cancer who are unsuitable for more toxic chemotherapy.
Related Publications
J P Iredale, and
L M Hooi, and
K M Kerr, and
M F Sudlow, and
C G Wathen
June 1995,
Lung cancer (Amsterdam, Netherlands),
J P Iredale, and
L M Hooi, and
K M Kerr, and
M F Sudlow, and
C G Wathen
January 1990,
European journal of cancer (Oxford, England : 1990),
J P Iredale, and
L M Hooi, and
K M Kerr, and
M F Sudlow, and
C G Wathen
January 1994,
Cancer chemotherapy and pharmacology,
J P Iredale, and
L M Hooi, and
K M Kerr, and
M F Sudlow, and
C G Wathen
January 1989,
Anticancer research,
J P Iredale, and
L M Hooi, and
K M Kerr, and
M F Sudlow, and
C G Wathen
January 2009,
Thorax,
J P Iredale, and
L M Hooi, and
K M Kerr, and
M F Sudlow, and
C G Wathen
January 1984,
Cancer chemotherapy and pharmacology,
J P Iredale, and
L M Hooi, and
K M Kerr, and
M F Sudlow, and
C G Wathen
March 1986,
Cancer treatment reports,
J P Iredale, and
L M Hooi, and
K M Kerr, and
M F Sudlow, and
C G Wathen
January 1988,
Onkologie,
J P Iredale, and
L M Hooi, and
K M Kerr, and
M F Sudlow, and
C G Wathen
January 1983,
Cancer treatment reports,
J P Iredale, and
L M Hooi, and
K M Kerr, and
M F Sudlow, and
C G Wathen
June 1995,
Seminars in oncology,
